Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gee

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Toxicology|February 28, 1997
Effect of saponin on the transmucosal passage of beta-lactoglobulin across the proximal small intestine of normal and beta-lactoglobulin-sensitised ratsJ M Gee, J M Wal, K Miller, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 25, 2000
K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinomaH O'Brien, J A Matthew, J M Gee, et al.
Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.
European Journal of Clinical Nutrition|June 1, 2007
Development of a food frequency questionnaire for the assessment of quercetin and naringenin intakeS Ranka, J M Gee, L Biro, et al.
International Journal of Cancer|October 23, 2001
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceE Glynne-Jones, M E Harper, L T Seery, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Toxicology|February 28, 1997
Effect of saponin on the transmucosal passage of beta-lactoglobulin across the proximal small intestine of normal and beta-lactoglobulin-sensitised ratsJ M Gee, J M Wal, K Miller, et al.
International Journal of Cancer|August 22, 1995
Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, I O Ellis, J F Robertson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 25, 2000
K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinomaH O'Brien, J A Matthew, J M Gee, et al.
Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.
European Journal of Clinical Nutrition|June 1, 2007
Development of a food frequency questionnaire for the assessment of quercetin and naringenin intakeS Ranka, J M Gee, L Biro, et al.
International Journal of Cancer|October 23, 2001
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceE Glynne-Jones, M E Harper, L T Seery, et al.
Pageof 11